Evidence map›Paper›PMID 36835050›Full record

ArticleInternational journal of molecular sciences2023

Is CCL2 an Important Mediator of Mast Cell-Tumor Cell Interactions in Oral Squamous Cell Carcinoma?

Bernhard Hemmerlein, Luisa Reinhardt, Bernhard Wiechens, Tatjana Khromov, Henning Schliephake, Phillipp Brockmeyer

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Bernhard HemmerleinInstitute of Pathology, Helios Klinikum Krefeld, 47805 Krefeld, Germany.
Luisa ReinhardtDepartment of Oral and Maxillofacial Surgery, University Medical Center Goettingen, 37075 Goettingen, Germany.
Bernhard WiechensDepartment of Orthodontics, University Medical Center Goettingen, 37075 Goettingen, Germany.ORCID 0000-0002-2323-5940
Tatjana KhromovInstitute for Clinical Chemistry, University Medical Center Goettingen, 37075 Goettingen, Germany.
Henning SchliephakeDepartment of Oral and Maxillofacial Surgery, University Medical Center Goettingen, 37075 Goettingen, Germany.ORCID 0000-0002-2008-7188
Phillipp BrockmeyerDepartment of Oral and Maxillofacial Surgery, University Medical Center Goettingen, 37075 Goettingen, Germany.ORCID 0000-0003-3694-2828
University of Göttingen · DEHelios Klinikum Krefeld · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, we aimed to evaluate the influence of interactions between mast cells (MCs) and oral squamous cell carcinoma (OSCC) tumor cells on tumor proliferation and invasion rates and identify soluble factors mediating this crosstalk. To this end, MC/OSCC interactions were characterized using the human MC cell line LUVA and the human OSCC cell line PCI-13. The influence of an MC-conditioned (MCM) medium and MC/OSCC co-cultures on the proliferative and invasive properties of the tumor cells was investigated, and the most interesting soluble factors were identified by multiplex ELISA analysis. LUVA/PCI-13 co-cultures increased tumor cell proliferation significantly (

Indexed as

Carcinoma, Squamous CellCell CommunicationChemokine CCL2Head and Neck NeoplasmsMast CellsMouth NeoplasmsCell Line, TumorChemokinesHumansLigandsSquamous Cell Carcinoma of Head and NeckCCL2 protein, humanChemokine CCL2ChemokinesLigandsCC chemokine ligand 2CCL2mast cellsMCP-1MCsoral squamous cell carcinomaOSCCsoluble factors

Identifiers

PMID36835050
PMCPMC9963724
OpenAlexW4320493454

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.